Concepedia

Miroslav Barančı́k

MB

Statistics

Publications

33

Citations

1.7K

H-Index

20

Active since

1999

Affiliations

Slovak Academy of Sciences(Current)

Centre of Experimental Medicine of the Slovak Academy of Sciences

Comenius University Bratislava

Institute of Normal and Pathological Physiology of the Slovak Academy of Sciences

Max Planck Institute for Heart and Lung Research

Miroslav Barančı́k is an author at Slovak Academy of Sciences specializing in medicine, pharmacology, and molecular pharmacology.

Publications per year

1999–2022

33

Publications

33

The Range of Adaptation by Collateral Vessels After Femoral Artery Occlusion

Inka Eitenmüller, Oscar L. Volger, Alexander Kluge et al. · Circulation Research · 2006 · 204 citations · Full text

, , +14

New Insight into P-Glycoprotein as a Drug Target

Albert Breier, Lenka Gibalová, Mário Šereš et al. · Anti-Cancer Agents in Medicinal Chemistry · 2012 · 154 citations

, , +15

Inhibition of the Cardiac p38-MAPK Pathway by SB203580 Delays Ischemic Cell Death

Miroslav Barančı́k, Patrik Htun, Claudia Strohm et al. · Journal of Cardiovascular Pharmacology · 2000 · 139 citations

, , +16

SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance

Miroslav Barančı́k, V. Boháčová, Janka Kvačkajová et al. · European Journal of Pharmaceutical Sciences · 2001 · 134 citations

, , +8

Inhibition of the ER-Kinase Cascade by PD98059 and UO126 Counteracts Ischemic Preconditioning in Pig Myocardium

Claudia Strohm, Miroslav Barančı́k, Marie-Luise v. Br hl et al. · Journal of Cardiovascular Pharmacology · 2000 · 110 citations

, , +17

1–5 of 33